Webinar: When FL Changes: Understanding Progression & Transformation
In this informative webinar, expert clinicians and individuals living with FL came together to explore how to recognise the signs of progression, available treatment options, and what to expect.
FLF’s CMO Shares Key Scientific Highlights from ASH 2024
FLF’s CMO highlights key takeaways from ASH 2024 on follicular lymphoma, from immunotherapy to new treatments.
Webinar: FL and You – Emotional Health & Wellbeing
Watch our recent webinar with a panel of inspiring individuals and expert speakers as they share uplifting personal stories, professional advice and the unique perspective of supporting a loved one with FL.
2024 End of Year Reflections
This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.
Unlock the Cure Gala Dinner Raises Over £800,000
We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.
Our Webinar Series – Register Your Interest
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.
Webinar: Relapsed Follicular Lymphoma – Essential Insights
This inspiring session on Relapsed FL, which took place on September 26th 2024, provided the audience with valuable expert discussion and a patient perspective.
$2.25 Million to Research United to CURE Follicular Lymphoma
This strategic alliance with LLS and IFLI will further accelerate pioneering research and help cure follicular lymphoma through our Research United to CURE FL program.
Latest follicular lymphoma research updates from recent scientific conferences
The team updates from recent scientific conferences on the latest research in follicular lymphoma, from cutting-edge therapies to genetic insights.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.